DaVita, Inc.

DaVita, Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.

DaVita, Inc., is a US-based medical care company that specializes in providing kidney dialysis treatments along with integrated healthcare delivery and management services.

Ticker: DVA

Humankind Value: $30.3 B

Revenue: $12.0 B

Market Cap: $10.3 B

(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)

Without trained and educated professionals to deliver care, gains in life expectancies that are possible due to medical research and innovative health technologies would remain only theoretical. DaVita, Inc. is responsible for positive Humankind Value, largely through Medical Services ($10.2 B), Healthcare R&D ($7.4 B), and Medical Devices ($6.2 B). Within the Humankind 100, DaVita, Inc. is a top-five company for Medical Services per dollar of revenue. The value associated with Medical Services, Healthcare R&D, and Medical Devices contains our estimation of 494,678.5 additional years lived by people worldwide. However, there is potential room for improvement with respect to Opioid Abuse (-$483.2 M). Medical Services is attached to this company as a result of its direct business activities. Healthcare R&D, Medical Devices, and Opioid Abuse are mostly or entirely a result of supply-chain relationships. For this firm, supply chain partners increase an already positive Humankind Value.

How the Humankind Value Methodology Drives the Rankings

We take a quantitative, data-driven approach to estimating the economic impact that companies have on investors, customers, employees, and society at large, rolling social responsibility into a single dollar value that we use to represent what a company is contributing to humanity. As far as we can tell, we're the first ones doing it this way.

LEARN MORE ABOUT OUR RESEARCH
How Methodology Drives the Rankings